Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Short-term Investments (2020 - 2023)

Historic Short-term Investments for SOPHiA GENETICS (SOPH) over the last 4 years, with Q1 2023 value amounting to $1.1 million.

  • SOPHiA GENETICS's Short-term Investments fell 9819.49% to $1.1 million in Q1 2023 from the same period last year, while for Mar 2023 it was $1.1 million, marking a year-over-year decrease of 9819.49%. This contributed to the annual value of $17.3 million for FY2022, which is 7608.11% down from last year.
  • Latest data reveals that SOPHiA GENETICS reported Short-term Investments of $1.1 million as of Q1 2023, which was down 9819.49% from $17.3 million recorded in Q4 2022.
  • In the past 5 years, SOPHiA GENETICS's Short-term Investments ranged from a high of $72.4 million in Q4 2021 and a low of $1.1 million during Q1 2023
  • Its 4-year average for Short-term Investments is $37.3 million, with a median of $31.4 million in 2022.
  • Per our database at Business Quant, SOPHiA GENETICS's Short-term Investments skyrocketed by 21847.27% in 2021 and then plummeted by 9819.49% in 2023.
  • Quarter analysis of 4 years shows SOPHiA GENETICS's Short-term Investments stood at $22.7 million in 2020, then skyrocketed by 218.47% to $72.4 million in 2021, then crashed by 76.08% to $17.3 million in 2022, then plummeted by 93.68% to $1.1 million in 2023.
  • Its Short-term Investments stands at $1.1 million for Q1 2023, versus $17.3 million for Q4 2022 and $31.4 million for Q3 2022.